Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities

American Journal of Medicine

Volumn 127, Issue 12, 2014, Pages 1148-1153

  Shlyankevich, Julia ^a   Mehta, Nehal N ^b   Krueger, James G ^c   Strober, Bruce ^d,e   Gudjonsson, Johann E ^f   Qureshi, Abrar A ^g   Tebbey, Paul W ^h   Kimball, Alexandra Boer ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^e PROBITY MEDICAL RESEARCH   (Canada)

^f UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^g BROWN UNIVERSITY   (United States)

^h International Psoriasis Council   (United States)

Author keywords

Atherosclerosis; Cardiovascular; Cardiovascular disease; Inflammation; Inflammatory pathway; Interleukin 17; Metabolic syndrome; Psoriasis

Indexed keywords

ADALIMUMAB; BIOLOGICAL PRODUCT; C REACTIVE PROTEIN; CANAKINUMAB; CARDIOVASCULAR AGENT; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 20; INTERLEUKIN 22; INTERLEUKIN 36; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; TRANSCRIPTOME; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COMORBIDITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FATTY ACID METABOLISM; GENOTYPE ENVIRONMENT INTERACTION; HEART INFARCTION; HEREDITY; HUMAN; INCIDENCE; INFLAMMATION; KNOWLEDGE; METABOLIC SYNDROME X; PATHOGENESIS; PHOTOTHERAPY; PSORIASIS; PUBLICATION; REVIEW; SYSTEMIC THERAPY; ANTAGONISTS AND INHIBITORS; CARDIOVASCULAR DISEASES; IMMUNOLOGY; T LYMPHOCYTE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; COMORBIDITY; HUMANS; INFLAMMATION; INTERLEUKIN-17; METABOLIC SYNDROME X; PSORIASIS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84919667465     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2014.08.008     Document Type: Review

References (28)

1. A.W. Armstrong, C.T. Harskamp, and E.J. Armstrong Psoriasis and the risk of diabetes mellitus: a systematic review and meta-analysis JAMA Dermatol 149 2013 84 91
2. J. Wan, S. Wang, K. Haynes, M.R. Denburg, D.B. Shin, and J.M. Gelfand Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study BMJ 347 2013 f5961
3. J.J. Wu, K.Y. Poon, J.C. Channual, and A.Y. Shen Association between tumor necrosis factor inhibitor therapy and myocardial infarction risk in patients with psoriasis Arch Dermatol 148 2012 1244 1250
4. O. Ahlehoff, L. Skov, and G. Gislason Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study J Intern Med 273 2013 197 204
5. N.N. Mehta, K. Li, P. Szapary, J. Krueger, and C. Brodmerkel Modulation of cardiometabolic pathways in skin and serum from patients with psoriasis J Transl Med 11 2013 194
6. M. Suarez-Farinas, K. Li, J. Fuentes-Duculan, K. Hayden, C. Brodmerkel, and J.G. Krueger Expanding the psoriasis disease profile: Interrogation of the skin and serum of patients with moderate-to-severe psoriasis J Invest Dermatol 132 2012 2552 2564
7. S. Tian, J.G. Krueger, and K. Li Meta-analysis derived (MAD) transcriptome of psoriasis defines the "core" pathogenesis of disease PLoS One 7 2012 e44274
8. M. Butcher, and E. Galkina Current views on the functions of interleukin-17A-producing cells in atherosclerosis Thromb Haemost 106 2011 787 795
9. J.M. Gelfand, A.L. Neimann, D.B. Shin, X. Wang, D.J. Margolis, and A.B. Troxel Risk of myocardial infarction in patients with psoriasis JAMA 296 2006 1735 1741
10. J.M. Gelfand, E.D. Dommasch, and D.B. Shin The risk of stroke in patients with psoriasis J Invest Dermatol 129 2009 2411 2418
11. T. Henseler, and E. Christophers Disease concomitance in psoriasis J Am Acad Dermatol 32 1995 982 986
12. Y. Gupta, S. Moller, D. Zillikens, W.H. Boehncke, S.M. Ibrahim, and R.J. Ludwig Genetic control of psoriasis is relatively distinct from that of metabolic syndrome and coronary artery disease Exp Dermatol 22 2013 552 553
13. Y. Wang, H. Gao, and C.M. Loyd Chronic skin-specific inflammation promotes vascular inflammation and thrombosis J Invest Dermatol 132 2012 2067 2075
14. N.N. Mehta, Y. Yu, and B. Saboury Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study Arch Dermatol 147 2011 1031 1039
15. B.B. Davidovici, N. Sattar, and J. Prinz Psoriasis and systemic inflammatory diseases: Potential mechanistic links between skin disease and co-morbid conditions J Invest Dermatol 130 2010 1785 1796
16. A.B. Alexandroff, M. Pauriah, R.D. Camp, C.C. Lang, A.D. Struthers, and D.J. Armstrong More than skin deep: atherosclerosis as a systemic manifestation of psoriasis Br J Dermatol 161 2009 1 7
17. R.P. Nair, A. Ruether, and P.E. Stuart Polymorphisms of the IL12B and IL23R genes are associated with psoriasis J Invest Dermatol 128 2008 1653 1661
18. N.N. Mehta, F.C. McGillicuddy, and P.D. Anderson Experimental endotoxemia induces adipose inflammation and insulin resistance in humans Diabetes 59 2010 172 181
19. R. Shah, C.C. Hinkle, and L. Haris Adipose genes down-regulated during experimental endotoxemia are also suppressed in obesity J Clin Endocrinol Metab 97 2012 E2152 E2159
20. N.N. Mehta, S.P. Heffron, and P.N. Patel A human model of inflammatory cardio-metabolic dysfunction; a double blind placebo-controlled crossover trial J Transl Med 10 2012 124
21. S. Basu, H. Zaidi, and M. Houseni Novel quantitative techniques for assessing regional and global function and structure based on modern imaging modalities: Implications for normal variation, aging and diseased states Semin Nucl Med 37 2007 223 239
22. G.G. Bural, D.A. Torigian, and E. Botvinick A pilot study of changes in (18)F-FDG uptake, calcification and global metabolic activity of the aorta with aging Hell J Nucl Med 12 2009 123 128
23. N. Tahara, H. Kai, and M. Ishibashi Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography J Am Coll Cardiol 48 2006 1825 1831
24. B. Paulmier, M. Duet, and R. Khayat Arterial wall uptake of fluorodeoxyglucose on PET imaging in stable cancer disease patients indicates higher risk for cardiovascular events J Nucl Cardiol 15 2008 209 217
25. A. Rominger, T. Saam, and S. Wolpers 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease J Nucl Med 50 2009 1611 1620
26. J. Dave, M.A. Ahlman, B.N. Lockshin, D.A. Bluemke, and N.N. Mehta Vascular inflammation in psoriasis localizes to the arterial wall using a novel imaging technique J Am Acad Dermatol 70 2014 1137 1138
27. R. Chen, G.I. Mias, and J. Li-Pook-Than Personal omics profiling reveals dynamic molecular and medical phenotypes Cell 148 2012 1293 1307
28. N.J. Stone, J.G. Robinson, and A.H. Lichtenstein Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 ACC/AHA cholesterol guideline Ann Intern Med 160 2014 339 343